… Although surfactants do not improve mortality or MV duration … to COVID-19-induced ALI/ARDS
patients. The incidence of … as a promising focus of future research for ARDS as well as …

… At present, there is no specific treatment for ALI/ARDS. The … of dead alveolar cells and excess
alveolar surfactant (66, 67). In … potential therapeutic approach for ARDS patients, and future …

… for ALI/ARDS via its … /therapeutic potential and future direction of ALI/ARDS care with the
ultimate goal of better defining mechanistic subtypes (endotypes and theratypes) through new …

… AEC-IIs also secrete alveolar surfactants, regulate surfactant … to ALI/ARDS progression, as
it can decrease surfactant production … EVs and neutrophils during ALI/ARDS progression. This …

… The treatment and management of ALI/ARDS may be … using Citespace to serve as a reference
for relevant future research. … such as alveolar surfactant supplement therapy and moderate …

… Surfactant is mainly composed of lipids and related proteins, … drug that can effectively treat
ALI/ARDS. In light of this, … be done on immunotherapy for ALI in the future. It is important to fully …

… derived exosomes related to ALI/ARDS and provide insights … A series of therapeutic
strategies including surfactants [8], … Liquid therapy may lead to renal injury at different levels and …

… Therefore, through a comprehensive analysis of the … treatment strategy that could be a
selective alternative to global IL-6 inhibition in the future, but its therapeutic potential in ALI/ARDS …

… The ALI/ARDS spectrum of severe inflammatory conditions is … in the field and potential areas
of research for future studies. … or pulmonary surfactant, or indirectly through the generation of …

… recognizes heat shock and surfactant proteins and high mobility … -associated ALI/ARDS
requires viral activation, while TLR4 … of ignorance that needs to be rectified by future research. …